![Daniel Wallerstorfer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Daniel Wallerstorfer is a CEO & Chairman-Management Board at Darwin AG and a Chief Executive Officer at Novogenia GmbH.
Dr. Wallerstorfer was previously employed as a Co-Chief Executive Officer by Claya, Inc.
| Sociétés | Poste | Début |
|---|---|---|
| DARWIN AG | Directeur Général | 15/03/2021 |
Novogenia GmbH
 Novogenia GmbH Miscellaneous Commercial ServicesCommercial Services Provides medical genetic testing services | Directeur Général | 01/01/2009 |
| Sociétés | Poste | Fin |
|---|---|---|
Claya, Inc.
 Claya, Inc. Food RetailRetail Trade Operates as an online store for nutrition and supplements | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Novogenia GmbH
Novogenia GmbH Miscellaneous Commercial ServicesCommercial Services Provides medical genetic testing services | Commercial Services |
Claya, Inc.
Claya, Inc. Food RetailRetail Trade Operates as an online store for nutrition and supplements | Retail Trade |
Darwin AG
 Darwin AG BiotechnologyHealth Technology Engages in research and development in the field of biotechnology | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
